{
    "nctId": "NCT00156806",
    "briefTitle": "Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.",
    "officialTitle": "Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer.",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 231,
    "primaryOutcomeMeasure": "Skin reaction severity.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* adult age women receiving 4500cGy or 5000cGy for non-metastatic breast cancer.\n* tumor bed boost allowed.\n\nExclusion Criteria:\n\n* patients with uncontrolled diabetes, uncontrolled eating disorder, acquired immunodeficiency syndrome, active lupus or scleroderma, a known allergy to pure aloe gel, a pre-study contact dermatitis to study creams.\n* consenting procedures not completed prior to 10cGy of radiation therapy.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}